Thus it was evident that overall alterations (deletion/methylation) of SH3GL2 was high (63%, 19/30) in dysplastic lesions and became comparable (64%–77%) in subsequent stages of tumor progression (Figure 3f). Here, SH3GL2 is linked to neoplasm.